首页|期刊导航|基础医学与临床|瑞马唑仑预处理减轻肝脏缺血/再灌注模型大鼠肝功能损伤

瑞马唑仑预处理减轻肝脏缺血/再灌注模型大鼠肝功能损伤OA

Remimazolam pretreatment alleviates liver injury in rat models with liver ischemia-reperfusion

中文摘要英文摘要

目的 探讨瑞马唑仑(REM)预先给药对肝缺血/再灌注损伤(HI/RI)大鼠全身氧化应激和炎性反应以及肝细胞凋亡的影响.方法 取 SPF 级雄性 SD 大鼠 30 只,体质量 220~280 g,按随机数字表法分为 3 组(n=10):假手术组(sham 组,仅行开腹)、模型组(HI/R 组,建立 70%肝脏缺血 60 min 后再灌注 6h 的模型)、干预组(REM组,于肝缺血前 10 min,经尾静脉注射 REM 10 mg/kg).再灌注6h 后,大鼠实施安乐死,采集腔静脉血及肝左叶组织.采用全自动生化仪检测血清中 AST 和 ALT;ELISA 检测 TNF-α、IL-1β 和 IL-6 的表达水平;HE 染色观察肝组织病理学改变;采用硫代巴比妥酸(TBA)检测 MDA 含量;黄嘌呤氧化酶(XOD)检测 SOD 活性;Western blot 检测凋亡相关蛋白 Bax 和 Bcl-2 的表达;TUNEL 检测肝脏组织细胞凋亡指数(AI).结果 缺血/再灌注处理后,HI/R组大鼠血清肝酶(AST、ALT)及促炎介质(TNF-α、IL-1β、IL-6)表达水平均较 sham 组显著升高(P<0.01),肝组织脂质过氧化产物 MDA 及促凋亡蛋白 Bax 表达显著升高(P<0.01),而内源性抗氧化酶 SOD 活性及抗凋亡蛋白 Bcl-2 表达明显降低(P<0.01),肝细胞 AI 显著升高(P<0.01).经瑞马唑仑预处理后,REM 组血清中 AST、ALT、TNF-α、IL-1β 和 IL-6 表达水平较 HI/R 组明显降低(P<0.01),肝脏组织 MDA 和 Bax 蛋白表达明显降低(P<0.01),而 SOD 活性和 Bcl-2 蛋白表达显著升高(P<0.01),肝细胞 AI 明显降低(P<0.01).结论 瑞马唑仑预先给药能够减轻大鼠肝脏缺血/再灌注引起的肝功能损伤,其机制与抑制全身氧化应激、减轻炎性反应及缓解肝细胞凋亡有关.

Objective To investigate the effects of remazolam(REM)pretreatment on systemic oxidative stress,inflammation and apoptosis of liver cells in hepatic ischemia-reperfusion injury(HI/RI)rats.Methods Thirty SPF-grade male SD rats with body weight of 220-280 g,were randomly divided into 3 groups(n=10):sham oper-ation group(sham group,only laparotomy),model group(HI/R group,a model was established with 70%liver ischemia for 60 minutes and then reperfusion for 6 hours),and intervention group(REM group,REM 10 mg/kg was injected via the tail vein 10 minutes before liver ischemia).Six hours after reperfusion,the rats were eutha-nized and vena cava blood and specimens of the left lobe of the liver were collected.Serum AST and ALT level were detected using an automatic biochemical analyzer.Serum level of the pro-inflammatory cytokines TNF-α,IL-1β,and IL-6 was measured by ELISA.Hepatic histo-pathological changes were observed using HE staining microscopy.The content of MDA was detected by thiobarbituric acid(TBA),and the activity of SOD was checked by xanthine oxidase(XOD).The expression of apoptosis-related proteins Bax and Bcl-2 was detected by Western blot.The ap-optosis index(AI)of liver tissue cells was detected by TUNEL.Results After ischemia-reperfusion treatment,the expression of serum liver enzymes(AST,ALT)and pro-inflammatory mediators(TNF-α,IL-1β,IL-6)in the HI/R group were significantly higher than those in the sham group(P<0.01).The expression of lipid peroxidation product MDA and pro-apoptotic protein Bax in liver tissue was significantly increased(P<0.01).The activity of endogenous antioxidant enzyme SOD and the expression of anti-apoptotic protein Bcl-2 and AI of liver cells were significantly decreased(P<0.01).After pretreatment with remimazolam,the expression levels of AST,ALT,TNF-α,IL-1β and IL-6 in the serum of the REM group were significantly lower than those in the HI/R group(P<0.01).The ex-pression of MDA and Bax protein in liver tissue was significantly decreased(P<0.01).While the activity of SOD and the expression of Bcl-2 protein were significantly increased(P<0.01).The AI of liver cells was significantly decreased(P<0.01).Conclusions REM pretreatment can alleviate HI/R-induced hepatic dysfunction via multi-targeted mechanisms:inhibition of systemic oxidative stress,reduction of inflammation and alleviation of hepatocyte apoptosis.

薛小红;和珊;孙凌霜;宋珂珂;黄健;周荣胜

西安交通大学第一附属医院 血液净化科,陕西 西安 710061西安交通大学第一附属医院 麻醉科,陕西 西安 710061西安交通大学第一附属医院 血液净化科,陕西 西安 710061西安交通大学第一附属医院 麻醉科,陕西 西安 710061西安交通大学第一附属医院 麻醉科,陕西 西安 710061西安交通大学第一附属医院 麻醉科,陕西 西安 710061

医药卫生

瑞马唑仑肝脏缺血/再灌注损伤氧化应激炎性反应凋亡

remazolamhepatic ischemia-reperfusion injuryoxidative stressinflammationapoptosis

《基础医学与临床》 2026 (9)

1221-1226,6

陕西省重点研发计划研究项目(2019SF-154)

10.16352/j.issn.1001-6325.2026.09.1221

评论